Europe aspires to set the record straight on familial hypercholesterolaemia

Affiliations

¹ School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia; Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, Western Australia, Australia. Electronic address: gerald.watts@uwa.edu.au.
² School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia.
³ Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, and Preventive Medicine Centre and Cardiology Program Hospital Israelita Albert Einstein, São Paulo, Brazil.

Comment

Gerald F Watts et al. Atherosclerosis. 2015 Aug.

. 2015 Aug;241(2):769-71.

doi: 10.1016/j.atherosclerosis.2015.04.016. Epub 2015 Apr 20.

¹ School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia; Lipid Disorders Clinic, Cardiovascular Medicine, Royal Perth Hospital, Western Australia, Australia. Electronic address: gerald.watts@uwa.edu.au.
² School of Medicine and Pharmacology, University of Western Australia, Western Australia, Australia.
³ Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, and Preventive Medicine Centre and Cardiology Program Hospital Israelita Albert Einstein, São Paulo, Brazil.

No abstract available

Keywords: Coronary care unit; Familial hypercholesterolaemia; Prevalence; Screening.

Comment on

Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.
De Backer G, Besseling J, Chapman J, Hovingh GK, Kastelein JJ, Kotseva K, Ray K, Reiner Ž, Wood D, De Bacquer D; EUROASPIRE Investigators. De Backer G, et al. Atherosclerosis. 2015 Jul;241(1):169-75. doi: 10.1016/j.atherosclerosis.2015.04.809. Epub 2015 Apr 30. Atherosclerosis. 2015. PMID: 25997074